A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer
研究单位:[1]Jiangsu HengRui Medicine Co.,Ltd.[2]The First Affiliated Hospital of Bengbu Medical College Bengbu,Anhui,China,233000[3]Anhui Chest Hospital Hefei,Anhui,China,230000[4]Anhui Provincial Cancer Hospital Hefei,Anhui,China,230000[5]Anhui Provincial Hospital Hefei,Anhui,China,230000[6]The First Affiliated Hospital Of Anhui Medical University Hefei,Anhui,China,230000[7]Beijing Cancer Hospital Beijing,Beijing,China,100000[8]Beijing Chest Hospital,Capital Medical University Beijing,Beijing,China,100000[9]Peking University Third Hospital Beijing,Beijing,China,100000[10]ChongQing University Cancer Hospital Chongqing,Chongqing,China,400000[11]Fujian Medical University Union Hospital Fuzhou,Fujian,China,350000[12]Fujian Provincial Cancer Hospital Fuzhou,Fujian,China,350000[13]The First Affiliated Hospital of Xiamen University Xiamen,Fujian,China,361000[14]The Second Affiliated Hospital of Xiamen Medical College Xiamen,Fujian,China,361000[15]The People's Hospital of Gaozhou Gaozhou,Guangdong,China,525200[16]Affiliated Cancer Hospital and Institute of Guangzhou Medical University Guangzhou,Guangdong,China,510000[17]The First Affiliated Hospital of Guangzhou Medical University Guangzhou,Guangdong,China,510000[18]The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou,Guangdong,China,510000[19]Meizhou People's Hospital (Huangtang Hospital) Meizhou,Guangdong,China,514000[20]Shantou Central Hospital Shantou,Guangdong,China,515000[21]Affiliated Hospital of Guangdong Medical University Zhanjiang,Guangdong,China,524000[22]Affiliated Hospital of Guilin Medical University Guilin,Guangxi,China,541000[23]Guangxi Medical University Affiliated Tumor Hospital Nanning,Guangxi,China,530000[24]The First Affiliated Hospital of Guangxi Medical University Nanning,Guangxi,China,530000[25]Affiliated Hospital of Zunyi Medical University Zunyi,Guizhou,China,563000[26]Hainan General Hospital Haikou,Hainan,China,570100[27]The Fourth Hospital of Hebei Medical University Shijiazhuang,Hebei,China,050000[28]North China University Of Science And Technology Affiliated Hospital Tangshan,Hebei,China,063000[29]Xingtai People's Hospital Xingtai,Hebei,China,054000[30]Haerbin Medical University Cancer Hospital Ha'erbin,Heilongjiang,China,150000[31]Anyang Cancer Hospital Anyang,Henan,China,455000[32]The First Affiliated Hosptial of Henan University of Science & Technology Luoyang,Henan,China,471000[33]Henan Cancer Hospital Zhengzhou,Henan,China,450000[34]The First Affiliated Hospital of Zhengzhou University Zhengzhou,Henan,China,450000[35]Shiyan Taihe Hospital Shiyan,Hubei,China,442000[36]Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan,Hubei,China,430000[37]Xiangyang Central Hospital Xiangyang,Hubei,China,441000[38]Army Medical Center of PLA Changsha,Hunan,China,410000[39]Hunan Cancer Hospital-Thoracic Medicine Department I Changsha,Hunan,China,410000[40]Hunan Cancer Hospital-Thoracic Medicine Department Ⅱ Changsha,Hunan,China,410000[41]Xiangya Hospital Central South University Changsha,Hunan,China,410000[42]Shaoyang Central Hospital Shaoyang,Hunan,China,422000[43]Zhuzhou Central Hospital Zhuzhou,Hunan,China,412000[44]Affiliated Drum Tower Hospital,Medical School of Nanjing University Nanjing,Jiangsu,China,210000[45]Zhongda Hospital Southeast University Nanjing,Jiangsu,China,210000[46]Nantong Tumor Hospital Nantong,Jiangsu,China,226000[47]Affiliated Hospital of JiangNan University Wuxi,Jiangsu,China,214000[48]The Affiliated Hospital of Xuzhou Medical University Xuzhou,Jiangsu,China,221000[49]Northern Jiangsu People's Hospital Yangzhou,Jiangsu,China,225000[50]First Affiliated Hospital of Gannan Medical University Ganzhou,Jiangxi,China,341000[51]The First Affiliated Hospital of Nanchang University Nanchang,Jiangxi,China,330000[52]The Second Affiliated Hospital of Nanchang University Nanchang,Jiangxi,China,330000[53]Liaoning Cancer Hospital Shenyang,Liaoning,China,110000[54]Shengjing Hospital Affiliated to China Medical University Shenyang,Liaoning,China,110000[55]The First Hospital of China Medical University Shenyang,Liaoning,China,110000[56]Chifeng City Hospital Chifeng,Neimenggu,China,024000[57]The Affiliated Hospital of Inner Mongolia Medical University Hohhot,Neimenggu,China,010000[58]Qilu Hospital of Shandong University Jinan,Shandong,China,250000[59]Shandong Cancer Hospital&Institute Jinan,Shandong,China,250000[60]The Affiliated of Qingdao University Qingdao,Shandong,China,266000[61]LinYi Cancer Hospital Linyi,Shangdong,China,276000[62]Fudan University Shanghai Cancer Center Shanghai,Shanghai,China,200000[63]Ruijin Hospital,Shanghai Jiao Tong University School of Medicine Shanghai,Shanghai,China,200000[64]Shanghai Chest Hospital Shanghai,Shanghai,China,200000[65]Shanghai Pulmonary Hospital Shanghai,Shanghai,China,200000[66]Baoji Central Hospital Baoji,Shanxi,China,721000[67]Changzhi People's Hospital Changzhi,Shanxi,China,046000[68]General Hospital of TISCO Taiyuan,Shanxi,China,030000[69]Shanxi Bethune Hospital Taiyuan,Shanxi,China,030000[70]Shanxi Provincial Cancer Hospital Taiyuan,Shanxi,China,030000[71]The Second Affiliated Hospital of Air Force Military University Tangdu Hospital Xi'an,Shanxi,China,710000[72]Sichuan Cancer Hospital Chengdu,Sichuan,China,610000[73]The Affiliated Hospital of Southwest Medical University Luzhou,Sichuan,China,646000[74]Mianyang Central Hospital Mianyang,Sichuan,China,621000[75]Yibin Second People's Hospital Yibin,Sichuan,China,644000[76]Tianjin Medical University Cancer Institute & Hospital Tianjin,Tianjin,China,300000[77]Yunnan Cancer Hospital Kunming,Yunnan,China,650000[78]Hangzhou Cancer Hospital Hangzhou,Zhejiang,China,310000[79]The First Affiliated Hospital,College of Medicine,Zhejiang University of Medicine Hangzhou,Zhejiang,China,310000[80]The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou,Zhejiang,China,310000[81]ZheJiang Cancer Hospital Hangzhou,Zhejiang,China,310000
研究目的:
The study is being conducted to evaluate the efficacy, and safety of camrelizumab combined with famitinib malate vs. pembrolizumab in treatment naïve subjects with programmed death-ligand 1(PD-L1)-positive recurrent or metastatic non-small cell lung cancer (NSCLC).